VistaGen Therapeutics Inc (NASDAQ:VTGN)

2.58
Delayed Data
As of 3:59pm ET
 -0.045 / -1.72%
Today’s Change
0.46
Today|||52-Week Range
3.18
+32.73%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for VistaGen Therapeutics Inc have a median target of 7.50, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +191.26% increase from the last price of 2.58.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in VistaGen Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.05
Sales
$304.5K
Reporting Date
Jun 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.14%
 
 
 
 
 
 
Growthannually 57.50%
 
 
 
 
 
 

Sales

Growthquarterly -2.89%
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.